BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2804 related articles for article (PubMed ID: 16509213)

  • 41. Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension.
    Ardhanari S; Kannuswamy R; Chaudhary K; Lockette W; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):185-95. PubMed ID: 25908467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A case report of idiopathic hyperaldosteronism characterized by bilateral adrenal adenoma.
    Wang W; Wei F; Li R; Tian J
    Medicine (Baltimore); 2019 Oct; 98(43):e17418. PubMed ID: 31651844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and management of primary aldosteronism: an updated review.
    Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
    Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
    Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
    Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Primary aldosteronism].
    Fardella CE; Mosso LM; Carvajal CA
    Rev Med Chil; 2008 Jul; 136(7):905-14. PubMed ID: 18949169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of aldosterone-producing adenoma with severe postoperative hyperkalemia.
    Taniguchi R; Koshiyama H; Yamauchi M; Tanaka S; Inoue D; Sato Y; Sugawa A; Muramatsu Y; Sasano H
    Tohoku J Exp Med; 1998 Nov; 186(3):215-23. PubMed ID: 10348217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary aldosteronism].
    Amar L
    Rev Prat; 2015 Jun; 65(6):817-21. PubMed ID: 26298907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Primary aldosteronism: diagnosis, laterality and regulation of hormone secretion].
    Vetter H; Vetter W; Beckerhoff R; Sobbe A; Nussberger J; Witassek F; Siegenthaler W
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1695-8. PubMed ID: 1215958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
    Chen YJ; Peng KY; Chueh JS; Liao HW; Hsieh TY; Wu VC; Wang SM
    Front Endocrinol (Lausanne); 2022; 13():816754. PubMed ID: 35399924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.
    Hennings J; Andreasson S; Botling J; Hägg A; Sundin A; Hellman P
    Langenbecks Arch Surg; 2010 Feb; 395(2):133-7. PubMed ID: 19418066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
    Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF
    J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical prediction score to diagnose unilateral primary aldosteronism.
    Küpers EM; Amar L; Raynaud A; Plouin PF; Steichen O
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3530-7. PubMed ID: 22918872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary hyperaldosteronism].
    Chambaz IC; Pechère-Bertschi A
    Rev Med Suisse; 2011 Sep; 7(308):1736-8, 1740-2. PubMed ID: 21954813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is primary aldosteronism underdiagnosed in clinical practice?
    Fiquet-Kempf B; Launay-Mignot P; Bobrie G; Plouin PF
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1083-6. PubMed ID: 11903321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors affecting parathyroid hormone levels in different types of primary aldosteronism.
    Jiang Y; Zhang C; Ye L; Su T; Zhou W; Jiang L; Zhang Y; Wang W
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):267-74. PubMed ID: 26589237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Idiopathic aldosteronism masquerading as discrete aldosterone-secreting adrenal cortical neoplasms among patients with primary aldosteronism.
    McLeod MK; Thompson NW; Gross MD; Grekin RJ
    Surgery; 1989 Dec; 106(6):1161-7; discussion 1168. PubMed ID: 2588119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary Aldosteronism: Present and Future.
    Funder JW
    Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 141.